Related posts

TSX and Dow gain for the weekcash, credit and health3 Best U.S. Healthcare ETFs
Investor Insights

This summary was created by AI, based on 20 opinions in the last 12 months.

Thermo Fisher Scientific is a global leader in scientific devices and tools for the bio-pharma industry. Despite challenges post-Covid, the company is expected to see revenue growth reaccelerate. The long-term prospects for this stock are positive, with steady earnings growth and a strong position in the healthcare industry. While there has been some inventory destocking and weaker demand, analysts generally view this stock favorably for long-term investors.

Consensus
positive
Valuation
fair value
Similar
Agilent Technologies, AG-N
TOP PICK

Touches all aspects of bio-pharma industry. For example, helps run pharmaceutical trials, and helps build and design new drugs. Everything you need, such as electron microscopes, to create new drugs and products. 

Weak coming out of Covid, as there was too much inventory in the system. Now primed to see revenue growth reaccelerate. Last time, Trump was favourable to healthcare and biotech. Low multiple relative to its historical average. Yield is 0.3%.

(Analysts’ price target is $658.90)
electrical / electronic
TOP PICK

Scores 10/10 in her book. A global leader in scientific devices. Earnings grew double digits in the past 5 years and she expects steady growth to come. They raised EPS guidance from $21.35 to $22.00. There's 17% upside.

(Analysts’ price target is $658.50)
electrical / electronic
PAST TOP PICK
(A Top Pick Sep 15/23, Up 9%)

Still owns business. Excellent business. Expecting earnings to grow. Ability to grow in USA very good. Slow and steady growth - defensive name. Very good for a long term investor. 

electrical / electronic
PAST TOP PICK
(A Top Pick Oct 23/23, Up 29%)

All the tools and services that the healthcare industry needs, so you get diversity with just the one stock. Very well managed. Long-term growth targets are 7-9%. Always improves margins. China is about 8% of revenues, a bit weaker. Biotech funding dried up with higher rates. Inventory destocking. Hopefully, those 3 factors are behind them.

electrical / electronic
WEAK BUY

Likes it. Great job improving ROE, pretty stable sales growth. Estimate for 2025 is 11-12% earnings growth. Technically, sets up well.

electrical / electronic
PAST TOP PICK
(A Top Pick Jul 07/23, Up 18%)

Benefitted from Covid, but afterwards there was too much inventory. But the PE fell from 30x to 20x, and is exiting the excess and entering a long cycle. Will grow earning 10-15% including by acquisition. Healthcare/pharma/biotech he expects will grow.

electrical / electronic
BUY

It made a buy list today and deserved it. They're starting to see a rebound after Covid. They have a lot of diagnostic equipment that's widely used across healthcare. Shares are earnings are coming out of the doldrums and starting to move up.

electrical / electronic
PAST TOP PICK
(A Top Pick Jul 20/23, Up 12%)

World leader, dominates the industry. Not cheap, but solid long-term grower.

electrical / electronic
PAST TOP PICK
(A Top Pick Sep 15/23, Up 18%)

Still very positive, especially as spending by pharmaceuticals is getting more robust.

electrical / electronic
BUY

They delivered today a strong earnings and revenue beat as they raised their full-year forecast. Thinks this the last quarter of revenue shrinkage before it gets a major rise in the second half of 2024.

electrical / electronic
PAST TOP PICK
(A Top Pick Jul 13/23, Up 4%)

Subdued returns. A leader, critical player in its sector. Stock's lagged due to inventory destocking, higher interest rates, and softer Chinese economy. These issues are largely resolved.

electrical / electronic
PAST TOP PICK
(A Top Pick Jul 20/23, Up 0.4%)

It is the leading company for testing new drugs. It has grown from acquisitions and is now growing at a rate of 5 to7% a year. Buy and hold.

electrical / electronic
PAST TOP PICK
(A Top Pick Jun 13/23, Up 9%)

Higher interest rates saw weaker funding in biotech. China had weak demand, though only about 8% of revenues. Still likes it long term for a picks and shovels play.

electrical / electronic
DON'T BUY
BDX vs. TMO

Avoid TMO because their revenues are flattening. Both trade at a high PE. BDX hasn't done much in share movement. He'd rather pay more for Boston Scientific which performs better.

electrical / electronic
PAST TOP PICK
(A Top Pick Sep 15/23, Up 5%)

Not a major growth company, but will grow steady. ~7% top line growth expected to continue. ~10% share price appreciation expected going forward. Will continue to hold in portfolio. 

electrical / electronic
Showing 1 to 15 of 94 entries

Thermo Fisher Scientific(TMO-N) Rating

Ranking : 5 out of 5

Bullish - Buy Signals / Votes : 16

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 17

Stockchase rating for Thermo Fisher Scientific is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Thermo Fisher Scientific(TMO-N) Frequently Asked Questions

What is Thermo Fisher Scientific stock symbol?

Thermo Fisher Scientific is a American stock, trading under the symbol TMO-N on the New York Stock Exchange (TMO). It is usually referred to as NYSE:TMO or TMO-N

Is Thermo Fisher Scientific a buy or a sell?

In the last year, 17 stock analysts published opinions about TMO-N. 16 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Thermo Fisher Scientific.

Is Thermo Fisher Scientific a good investment or a top pick?

Thermo Fisher Scientific was recommended as a Top Pick by on . Read the latest stock experts ratings for Thermo Fisher Scientific.

Why is Thermo Fisher Scientific stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Thermo Fisher Scientific worth watching?

17 stock analysts on Stockchase covered Thermo Fisher Scientific In the last year. It is a trending stock that is worth watching.

What is Thermo Fisher Scientific stock price?

On 2024-12-06, Thermo Fisher Scientific (TMO-N) stock closed at a price of $528.73.